|
SOL is an Italian multinational group operating in the production, applied research, and commercialization of technical, pure, and medicinal gases, as well as home medical care. The company serves industrial customers in sectors such as steel, metallurgy, glass, ceramics, metal fabrication, chemicals, pharmaceuticals, food and beverage, and oil, providing compressed, liquefied, and cryogenic gases along with equipment and services. In the healthcare sector, SOL supplies hospitals, research institutes, and assisted reproduction centers with medical products and integrated operational solutions, while its home care division provides therapies for chronic patients on behalf of national health systems. The group also engages in biotechnology, focusing on genomic diagnostics, molecular genetics, and bioinformatics pipelines, and produces energy from renewable sources. Founded in 1927, SOL operates globally and maintains a presence in multiple countries, serving a large base of industrial clients and patients through its subsidiaries and specialized business units. Summarised from the company's own disclosures, fiscal year ended Dec 2024 |
Industry Specialty Chemicals | Homepage solgroup.com |
| Sector Basic Materials | IR page solgroup.com/it | |
|
Tags
technical gases, medical gases, home care, biotechnology, genomic diagnostics, renewable energy, industrial gases, clinical diagnostics, bioinformatics, patient care, Vivisol, Personal Genomics, Diatheva, Cryolab
|
Press page — |
Metrics
| Valuation | |
|---|---|
| Market cap | € 4.736B |
| Market cap (USD) | $ 5.311B |
| P/E | 30.56 |
| PEG | 1.68 |
| P/BV | 4.39 |
| P/S | 2.88 |
| P/OCF | 15.92 |
| P/FCF | 49.77 |
| Dividend yield | — |
| Turnover / mcap | — |
| Returns | |
|---|---|
| ROE | 15.1% |
| ROI | 14.4% |
| ROIC | 15.8% |
| Profit margin | 9.4% |
| Growth | |
|---|---|
| Revenue growing | Yes |
| Profits growing | Yes |
| Revenue up 3y | Yes |
| Revenue up 5y | — |
| Earnings growth 3y (net profit CAGR) | 18.2% |
| Quality | |
|---|---|
| Profitable | Yes |
| Margin expanding | No |
| Buying back stock | No |
| Diluting (TTM) | No |
| Debt/Equity | — |
| Podcast bulls (TTM) | Sign up |
| Podcast bears (TTM) | Sign up |
| Podcast sentiment (TTM) | Sign up |
| Podcast sentiment % (TTM) | Sign up |
| News sentiment (TTM) | 55 |
| Quality score | 25.0% |
| Insiders | |
|---|---|
| Buys, 1w | Sign up |
| Buys, 1m | Sign up |
| Buys, 1y | Sign up |
| Sells, 1w | Sign up |
| Sells, 1m | Sign up |
| Sells, 1y | Sign up |
Sign up to see this company's insider trades
Filed figures
Lines the statements and their notes report beside the headline figures, read from the filings' XBRL as filed (no restatement applied), with figures computed from one filing's own lines. Cash-flow lines carry their cash direction: an outflow is negative. Each period links to its filing; a figure's period, report date and tag are in its tooltip.
| Figure | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 |
|---|---|---|---|---|---|
| Balance sheet detail | |||||
| Trade receivables (EUR) | 298M | 340M | 431M | 448M | 491M |
| ↳ YoY growth | +14.1% | +26.8% | +4.0% | +9.6% | |
| Cash and deposits (EUR) | 269M | 140M | 135M | 206M | 232M |
| Intangible assets (EUR) | 18.6M | 22.8M | 26.6M | 42M | 50.2M |
| Cash flow detail | |||||
| Operating cash flow (EUR) | 210M | 193M | 215M | 270M | 297M |
| Purchases of property, plant and equipment (EUR) | -106M | -123M | -121M | -164M | -202M |
| Purchases of intangible assets (EUR) | -11.7M | -9.15M | -9.83M | -25.4M | -17.9M |
| Change in receivables (cash effect) (EUR) | -29.4M | -25.7M | -106M | 13.4M | 49.4M |
| Change in inventories (cash effect) (EUR) | -13.8M | -1.83M | -13.8M | 14M | 8.39M |
| Change in payables (cash effect) (EUR) | 13.8M | 13.5M | 32.1M | 11.2M | -29.5M |
| Dividends paid (cash effect) (EUR) | -22.4M | -23.9M | -24.3M | -33.5M | -37.8M |
| Interest paid (cash effect) (EUR) | -7.89M | -8.15M | -7.74M | -11.7M | -18.3M |
| Income taxes paid (cash effect) (EUR) | -29.9M | -37.2M | -28.7M | 37.4M | 61M |
| Operating cash flow before change in receivables (EUR) | 240M | 218M | 321M | 257M | 248M |
| Free cash flow (OCF - PPE - intangibles) (EUR) | 92.2M | 60.1M | 83.8M | 80.3M | 77.3M |
| Income detail | |||||
| Total comprehensive income (EUR) | 97M | 99.6M | 146M | 147M | 152M |
| Comprehensive income to owners (EUR) | 92.6M | 95.4M | 142M | 141M | 145M |
| Reported | May 30, 2023 | May 30, 2023 | May 30, 2023 | Apr 23, 2024 | Apr 23, 2025 |
Sign up to see institutional holdings
Sign UpPodcast Mentions
Sign up to see podcast mentions and sentiment
Sign UpRegulated releases stored at eMarket Storage and 1INFO, newest first, titles as filed, own-share transactions, internal dealing, holdings and voting-rights notices included. The link opens the filed PDF. Press releases from the company's own website, newest first.
28/10/2026
Acquisizione del 100% del capitale sociale della società Wentimed, fondata dal Dott. Piotr Compała, specializzata nei trattamenti domiciliari di ventilazione meccanica e cure palliative.
Il Gruppo SOL, multinazionale operante nel settore dei gas tecnici, industriali e medicinali e nel settore dell'assistenza domiciliare con il marchio "VIVISOL", annuncia di aver rafforzato la propria posizione in Polonia con l’acquisizione del 100% di Wentimed.
Fondata nel 2014 dal Dott. Piotr Compała, che ne ha guidato la crescita favorendo un rapido e significativo sviluppo, nel 2025 Wentimed ha raggiunto un fatturato di oltre 40 milioni di PLN (oltre 9 milioni di euro) e attualmente impiega oltre 100 dipendenti interni ed esterni. Il Dott. Compała continuerà a lavorare in Wentimed a fianco di SOL per la fase di transizione.
Maggiori dettagli nel Comunicato Stampa.
tags:
share:
Ottavo gruppo mondiale, sesto in Europa e maggiore operatore italiano indipendente dalle grandi multinazionali del settore, il Gruppo SOL è proiettato verso il futuro ma con salde radici nel passato.
quick links
contatti
-
Sede legale e Direzione:
Via Borgazzi, 27 - 20900 Monza (MB) Italy -
+39 039 23 96 1
-
P. IVA: 00771260965
Copyright © 2026 - All rights reserved - Privacy Policy
Reset filtri
Paesi
Global
Filtra per area
Global Assistenza domiciliare Biotecnologie Gas tecnici Energia
Torna indietro
Ottavo gruppo mondiale, sesto in Europa e maggiore operatore italiano indipendente dalle grandi multinazionali del settore, il Gruppo SOL è proiettato verso il futuro ma con salde radici nel passato.
quick links
contatti
-
Sede legale e Direzione:
Via Borgazzi, 27 - 20900 Monza (MB) Italy -
+39 039 23 96 1
-
P. IVA: 00771260965
Copyright © 2026 - All rights reserved - Privacy Policy
Prompts
Click prompts to add them under the company line, click again to take one out, then copy the result into your AI chat. Shared by Asian Century Stocks and Uncovered Thai Stocks. Thank you.
ETFs Holding SOL S.p.A.
Exchange-traded funds whose newest published daily portfolio holds one of the company's listings, largest weight first.
| ETF | Weight in ETF | Shares | Market value | As of |
|---|---|---|---|---|
| DFIS | 0.05% | 41,895 | $ 2.949M | Nov 12, 2026 |
| AVSD | 0.02% | 958 | $ 69.56K | Nov 16, 2026 |
| DFSI | 0.02% | 3,338 | $ 234.938K | Nov 12, 2026 |
| DFIC | 0.01% | 28,387 | $ 1.998M | Nov 12, 2026 |
| DFAX | 0.01% | 17,647 | $ 1.242M | Nov 12, 2026 |
| DFAI | 0.00% | 11,820 | $ 831.925K | Nov 12, 2026 |
| DXIV | 0.00% | 145 | $ 10.206K | Nov 12, 2026 |
| AVDE | 0.00% | 2,597 | $ 188.568K | Nov 16, 2026 |